Trial intelligence / Profile preview

Goal-directed fluid therapy (GDFT) during DIEP free flap breast reconstruction

2023-506152-24-00Phase 4Completed

Sponsor
AZ Maria Middelares
Start
Sep 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of plasma-lyte and norepinephrine in hypotension (2 arms), sponsored by AZ Maria Middelares. Primary endpoint: Total intraoperative fluid volume. Started Sep 2023; status: completed.

02

Drugs

plasma-lytenorepinephrine
03

Conditions

hypotension

Beyond the preview

Go deeper on 2023-506152-24-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2023-506152-24-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call